课题基金 / 基金详情

Dideoxynucleosides as Potential Anti-AIDS Drugs

Dideoxynucleosides as Potential Anti-AIDS Drugs
双脱氧核苷作为潜在的抗艾滋病药物
批准号:
7337934
负责人:
VICTOR MARQUEZ
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

VICTOR MARQUEZ的其他基金

相似基金

相关文献

中文摘要
翻译
基于我们在碳环核苷(Z01 BC 006174)项目中关于“延迟链终止”机制的经验教训,今年我们实施了两条调查路线,以利用有效抗HIV活性所需的每个关键参数:(1)将4'-烷基(甲基和乙基)连接到2'-脱氧核糖片段;(2)在双环[3.1.0]己烷核苷的碳环部分结合双键,使其转化为扁平的双环[3.1.0]己-3-烯核苷。环平坦度被认为是细胞激酶有效磷酸化所必需的特性。重点介绍了这两个方面的进展:(1)成功合成了含4′-甲基和乙基的胸腺嘧啶系列。4'-甲基类似物在体外作为5'-三磷酸盐用于抗HIV-RT时表现出优异的延迟链终止物特性,但未能被细胞激酶识别。以腺嘌呤为核碱基的类似系列的合成正在进行中;(2)用含胸腺嘧啶的扁平双环[3.1.0]己-3-烯合成首个南方类似物
英文摘要
Based on the lessons learned from our project on carbocyclic nucleosides (Z01 BC 006174) regarding the mechanism of "delayed chain termination", two lines of investigation have been implemented this year to exploit each of the critical parameters necessary for efficient activity against HIV: (1) attachment of 4'-alkyl groups (methyl and ethyl) to a 2'-deoxyribose moiety; and (2) incorporation of a double bond onto the carbocyclic moiety of bicyclo[3.1.0]hexane nucleosides converting them into flat bicyclo[3.1.0]hex-3-ene nucleosides. Ring flatness is a property deemed essential for efficient phosphorylation by cellular kinases. Progress in these two areas is highlighted: (1) Synthesis of the thymidine series bearing 4'-methyl and ethyl groups was successfully completed. The 4'-methyl analogue showed excellent properties as a delayed chain terminator when used in vitro against HIV-RT as a 5'-triphosphate, but failed to be recognized by cellular kinases. The synthesis of an analogous series with adenine as nucleobase is in progress; and (2) The synthesis of the first South analogue with a flat bicyclo[3.1.0]hex-3-ene containing thymi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
Dideoxynucleosides as Potential Anti-AIDS Drugs
Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs
COMPUTER-AIDED DRUG DESIGN MINICORE FACILITY PROJECT
国内基金
海外基金
Transient Receptor Potential 通道 A1在膀胱过度活动症发病机制中的作用
  • 批准号:
    30801141
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    28.0万元
  • 批准年份:
    2008
  • 负责人:
    都书琪
  • 依托单位: